Abstract:Helicobacter pylori, the world's most common chronic infection-causing pathogen, is responsible for causing gastric ulcers, the fourth-leading cause of cancer-related death globally in 2020. In recent years, the effectiveness of the current treatment regimen (two antibiotics and one proton pump inhibitor) has often been plagued with problems such as resistance and the undesired elimination of commensal bacteria. Herein, we report the synthesis of block and random copolycarbonates, functionalized with cationic guanidinium and anionic acetate functional groups, aimed at selectively killing H. pylori in the acidic environment of the stomach, while remaining nontoxic to the commensal bacteria in the gut. The compositions of the polymers were fine-tuned so that the polymers were readily dispersed in water without any difficulty at both pH 3.0 and 7.4. The self-assembly behavior of the polymers at different pH values by dynamic light scattering showed that the random and block copolymers formed stable micelles in a simulated gastric environment (pH 3.0) while aggregated at pH 7.4. Both polymers demonstrated stronger antibacterial activity against H. pylori than the guanidinium-functionalized homopolymer without any acetate functional group at pH 3.0. The block copolymer was significantly more bactericidal at pH 3.0 across the concentrations tested, as compared to the random copolymer, while it did not show significant toxicity toward rat red blood cells (rRBCs) and HK-2 cells or bactericidal effect toward E. coli (a common gut bacterium) and nor caused aggregation of rRBCs at its effective concentration and at physiological pH of 7.4. Additionally, both the block and random copolymers were much more stable against hydrolysis at pH 3.0 than at pH 7.4. This study provides insight into the influence of both polymer architecture and dynamic assembly on the bioactivities of antimicrobial polymers, where the disassembly of coacervates into narrowly dispersed micelles at pH 3 make them potent antimicrobials aided by the protonated carboxylic acid block.

Overcoming antibiotic resistance caused by genetic mutations of Helicobacter pylori with mucin adhesive polymer-based therapeutics

Selective Killing of Helicobacter Pylori with Ph-Responsive Helix-Coil Conformation Transitionable Antimicrobial Polypeptides.

Helicobacter pylori-targeting multiligand photosensitizer for effective antibacterial endoscopic photodynamic therapy

Bacteria-targeting Chitosan/carbon Dots Nanocomposite with Membrane Disruptive Properties Improve Eradication Rate of Helicobacter Pylori

Preparation and Evaluation of Lipid Polymer Nanoparticles for Eradicating H-Pylori Biofilm and Impairing Antibacterial Resistance in Vitro

Copper-Bearing Metal-Organic Framework with Mucus-Penetrating Function for the Multi-Effective Clearance of Mucosal Colonized Helicobacter Pylori

Engineering Bioinspired Bacteria-Adhesive Clay Nanoparticles with A Membrane-Disruptive Property for the Treatment of Helicobacter Pylori Infection

pH-Responsive Polymeric Micelle Dynamic Complexes for Selective Killing of Helicobacter pylori

Metal‐Organic Framework Based Mucoadhesive Nanodrugs for Multifunction Helicobacter Pylori Targeted Eradication, Inflammation Regulation and Gut Flora Protection

Gastro protective natural polymer aided triple drug therapy to eradicate Helicobacter pylori

Mucus Penetration Enhanced Lipid Polymer Nanoparticles Improve the Eradication Rate of Helicobacter Pylori Biofilm.

An all-in-one therapeutic platform for the treatment of resistant Helicobacter pylori infection

An antibiotic-free platform for eliminating persistent Helicobacter pylori infection without disrupting gut microbiota

Rubropunctatin-silver composite nanoliposomes for eradicating Helicobacter pylori in vitro and in vivo

Biomaterials for Helicobacter Pylori Therapy: Therapeutic Potential and Future Perspectives

Mucus‐Penetrating Nanoassembly as Potential Oral Phototherapeutic Formulation against Multi‐Drug Resistant Helicobacter pylori Infection

Advanced Interpenetrating Polymer Networks for Innovative Gastroretentive Formulations Targeting Helicobacter pylori Gastric Colonization

Construction and Optimization of Ph-Sensitive Nanoparticle Delivery System Containing PLGA and UCCs-2 for Targeted Treatment of Helicobacter Pylori.

Effective Treatment of Helicobacter pylori Infection Using Supramolecular Antimicrobial Peptide Hydrogels

Mucoadhesive Microspheres: A Promising Delivery System for Helicobacter Pylori (H. pylori) Treatment

Antimicrobial Peptide Hydrogel with pH-Responsive and Controllable Drug Release Properties for the Efficient Treatment of Helicobacter pylori Infection